The management of retroperitoneal soft tissue sarcomas

被引：33

作者：

Jenkins, MP ^{[1
]}

Alvaranga, JC ^{[1
]}

Thomas, JM ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP,SOFT TISSUE SARCOMA UNIT,LONDON SW3 6JJ,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 04期

关键词：

sarcoma; retroperitoneal sarcoma; management;

D O I：

10.1016/0959-8049(95)00638-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Over a 5-year period, all retroperitoneal soft tissue sarcomas (119) referred to the Royal Marsden Hospital, London, U.K., were recorded prospectively on a database and managed with a consistent treatment policy. On multivariate analysis, the significant factors responsible for determining prognosis were grade and completeness of excision. Despite improvements in surgical clearance rates (nearly 50% completely excised in this series), the prognosis was poor with 2- and 5-year survival rates of 53 and 20%, respectively. Further improvements in survival rates will depend on better adjuvant treatment. (C) 1996 Published by Elsevier Science Ltd

引用

页码：622 / 626

页数：5

共 36 条

[1] LIMITATIONS OF SURGERY IN THE TREATMENT OF RETROPERITONEAL SARCOMA [J].

ALVARENGA, JC ;

BALL, ABS ;

FISHER, C ;

FRYATT, I ;

JONES, L ;

THOMAS, JM .

BRITISH JOURNAL OF SURGERY, 1991, 78 (08) :912-916

[2] ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN IN HIGH-GRADE SOFT-TISSUE SARCOMA - A RANDOMIZED TRIAL OF THE SCANDINAVIAN-SARCOMA-GROUP [J].

ALVEGARD, TA ;

SIGURDSSON, H ;

MOURIDSEN, H ;

SOLHEIM, O ;

UNSGAARD, B ;

RINGBORG, U ;

DAHL, O ;

NORDENTOFT, AM ;

BLOMQVIST, C ;

RYDHOLM, A ;

STENER, B ;

RANSTAM, J .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1504-1513

[3] SILICONE IMPLANT TO PREVENT VISCERAL DAMAGE DURING ADJUVANT RADIOTHERAPY FOR RETROPERITONEAL SARCOMA [J].

BALL, ABS ;

CASSONI, A ;

WATKINS, RM ;

THOMAS, JM .

BRITISH JOURNAL OF RADIOLOGY, 1990, 63 (749) :346-348

[4]

BEVILACQUA RG, 1991, ARCH SURG-CHICAGO, V126, P328

[5] RETROPERITONEAL LIPOSARCOMA [J].

BINDER, SC ;

KATZ, B ;

SHERIDAN, MFB .

ANNALS OF SURGERY, 1978, 187 (03) :257-261

[6] ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP [J].

BRAMWELL, V ;

ROUESSE, J ;

STEWARD, W ;

SANTORO, A ;

SCHRAFFORDTKOOPS, H ;

BUESA, J ;

RUKA, W ;

PRIARIO, J ;

WAGENER, T ;

BURGERS, M ;

VANUNNIK, J ;

CONTESSO, G ;

THOMAS, D ;

VANGLABBEKE, M ;

MARKHAM, D ;

PINEDO, H .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1137-1149

[7] OUTCOME AND PROGNOSIS IN RETROPERITONEAL SOFT-TISSUE SARCOMA [J].

CATTON, CN ;

OSULLIVAN, B ;

KOTWALL, C ;

CUMMINGS, B ;

HAO, Y ;

FORNASIER, V .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (05) :1005-1010

[8]

CERAN AG, 1970, AM J SURG, V119, P288

[9]

COX DR, 1984, ANAL SURVIVAL DATA, P2

[10]

DALTON RR, 1989, SURGERY, V106, P725

← 1 2 3 4 →